haku: @author Charnes, J.M. / yhteensä: 2
viite: 1 / 2
« edellinen | seuraava »
| Tekijä: | Charnes, J.M. Kellogg, D. |
| Otsikko: | Real-options valuation for a biotechnology company |
| Lehti: | Financial Analysts' Journal
2000 : MAY-JUN, VOL. 56:3, p. 76-87 |
| Asiasana: | Bio-technology industry Pharmaceutical industry Valuation |
| Kieli: | eng |
| Tiivistelmä: | Many companies in the biotechnology industry have significant valuations despite having no product revenue because their products are in early stages of development. The authors explain the decision-tree method and binominal-lattice method (which adds a growth option) and use them to value a biotechnology company, Agouron Pharmaceuticals, as the sum of the value of its drug-development projects. |
« edellinen | seuraava »
SCIMA